European Congress of Digital Pathology 2023
Event Overview
At the European Congress of Digital Pathology, pathology professionals will share novel aspects of integrative pathology, discuss the strengths of the implementation of a digital workflow and promote the benefits and future applications of an AI-aided working environment. The integrative dimension of this meeting will be represented by the combination of histology with molecular profiling.
To schedule a meeting with our team during the ECDP2023, please contact Irene Yujnovsky at iyujnovsky@nanostring.com.
Visit us at booth #27
NanoString Symposium | Friday 16 June | 08:00 – 08:45 AM, Valletta I
The Spatial Biology Revolution: multiomic tissue analysis powered by a cloud-based fully integrated informatics platform
The NanoString symposium will showcase our innovative discovery and translational research spatial solutions.
Joachim Schmid will introduce how our platforms allow researchers to combine whole tissue imaging, gene expression, and protein data. Achieve multicellular analysis with GeoMx® Digital Spatial Profiler, or zoom in to view single cells with the CosMx™ Spatial Molecular Imager (SMI). Join us to see into the private lives of these cells in situ, at both cellular and subcellular levels supported by AtoMx™ Spatial Informatics Platform (SIP). Gain spatial biology insights anytime, anywhere using AtoMx™, a cloud-basedsolution that provides advanced data analytics and global collaboration capabilities.
- Achieve multicellular analysis with GeoMx® Digital Spatial Profiler, or zoom in to view single cells with the CosMx™ Spatial Molecular Imager (SMI).
- See into the private lives of these cells in situ, at both cellular and subcellular levels supported by AtoMx™ Spatial Informatics Platform (SIP).
- Gain spatial biology insights anytime, anywhere using AtoMx™, a cloud-based solution that provides advanced data analytics and global collaboration capabilities.
Nina Radosevic’s team used GeoMx DSP to find potential biomarkers and/or therapeutic targets in triple negative breast cancers that relapse rapidly after or progress under neoadjuvant chemotherapy. GeoMx DSP was crucial in revealing 2 proteins specifically highly expressed in the tumor center of such tumors as well as the disappearance of one biological process in those cases compared to the never-relapsing ones.
Nina Radosevic, PhD.
Biopathologist and Platform Director, Centre Jean Perrin
Joachim Schmid
VP of R&D Spatial Informatics, NanoString Technologies